To the Editor: BCG is an effective vaccine to prevent tuberculosis (TB) in young children travelling to countries with a high prevalence of TB.1 Although it does not completely mitigate the risk of developing TB, nor the need for preventive therapy after a significant TB exposure, it provides about 80% protection against the severe forms of TB that affect infants and young children.2 In Australia, routine BCG vaccination ceased in 1985, and vaccination of children now effectively relies on the initiative of parents. A study in the United Kingdom reported that only 6% of parents were aware of national BCG vaccination recommendations.3 We aimed to determine the proportion of mothers from high-TB-prevalence countries giving birth in Australia who were planning to travel to these countries with their newborn child, and to assess their knowledge of the need to BCG-vaccinate their child.
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- 1. Ritz N, Connell TG, Curtis N. To BCG or not to BCG? Preventing travel-associated tuberculosis in children. Vaccine 2008; 26: 5905-5910.
- 2. Trunz BB, Fine P, Dye C. Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness. Lancet 2006; 367: 1173-1180.
- 3. Gordon M, Roberts H, Odeka E. Knowledge and attitudes of parents and professionals to neonatal BCG vaccination in light of recent UK policy changes: a questionnaire study. BMC Infect Dis 2007; 7: 82.
- 4. Fulford M, Keystone JS. Health risks associated with visiting friends and relatives in developing countries. Curr Infect Dis Rep 2005; 7: 48-53.
No relevant disclosures.